Terumo Corp (OTC Pink - Limited Information:TRUMF)

29.50
Delayed Data
As of Jan 26
 +0.193 / +0.66%
Today’s Change
26.20
Today|||52-Week Range
37.99
+2.23%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$21.9B

Company Description

Terumo Corp. engages in the manufacturing and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan.

Contact Information

Terumo Corp.
2-44-1 Hatagaya
Tokyo Tokyo 151-0072
P:(133) 374-8111
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Shinjiro SatoPresident, CEO & Representative Director
Naoki MutoChief Financial & Accounting Officer
Kazuhisa SenshuChief Clinical & Regulatory Affairs Officer
Katsuya TakeuchiChief Information Officer & Executive Officer
Shouji HatanoDirector, Head-Compliance & Legal Affairs